PT-141 vs Melanotan II
A detailed comparison to help you understand the differences and choose the right peptide for your research.
PT-141 and Melanotan II both enhance libido through melanocortin receptor activation, but they differ significantly in their effects and regulatory status. PT-141 was specifically designed from Melanotan II to isolate the libido-enhancing effects without the tanning, and has achieved FDA approval. Melanotan II produces both tanning and libido effects.
Quick Comparison
Key Similarities
- Both enhance sexual desire through melanocortin receptors
- Both work centrally in the brain (not blood flow)
- Both cause nausea as a common side effect
- Both affect both men and women
- Both administered via subcutaneous injection
- Both work through the same general pathway
Key Differences
- PT-141 is FDA-approved; MT-II is not
- MT-II causes tanning; PT-141 does not
- PT-141 is on-demand; MT-II requires buildup
- MT-II has broader receptor activation
- PT-141 has more clinical safety data
- MT-II may affect moles (skin cancer concern)
- PT-141 is more targeted/selective
When to Choose Each
Choose PT-141
Choose PT-141 if you want only libido enhancement without tanning, prefer FDA-approved safety data, or want on-demand use. It's the cleaner, more targeted option specifically developed for sexual desire.
Choose Melanotan II
Choose Melanotan II if you want both tanning and libido effects, don't mind the skin darkening, or prefer the lower cost of research peptides. Monitor moles carefully with any tanning peptide.
Can You Stack Them?
Stacking is generally not recommended as both activate the same receptor pathway for libido. Choose one based on whether you want tanning effects. If using either, the libido effects are already maximized.
Frequently Asked Questions
References
- Kingsberg SA, et al. "Bremelanotide HSDD trials." JAMA, 2019. PMID: 31577365
- Wessells H, et al. "Melanotan II effects." J Urol, 2000. PMID: 10711309
Get the Complete Comparison Guide
Download our detailed comparison charts and decision framework.